Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Post-hospital Thrombosis Prevention Trial: An Adaptive, Multicenter, Prospective, Randomized Platform Trial Evaluating the Efficacy and Safety of Antithrombotic Strategies in Patients With COVID-19 Following Hospital Discharge

NCT04650087 is registered in ClinicalTrials.gov with Thomas L. Ortel as lead sponsor.

NCT NCT04650087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04650087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Post-hospital Thrombosis Prevention Trial: An Adaptive, Multicenter, Prospective, Randomized Platform Trial Evaluating the Efficacy and Safety of Antithrombotic Strategies in Patients With COVID-19 Following Hospital Discharge
Lead sponsor
Thomas L. Ortel
Phase
Phase 3
Overall status
Completed
Start date
February 15, 2021
Completion date
September 23, 2022
Enrollment
1,291 (actual)
Sites
121

Conditions

As the registry lists them; a condition with its own page is linked.

covid19